Folgen
David Ian Fisher
David Ian Fisher
Associate Principal Scientist, AstraZeneca
Bestätigte E-Mail-Adresse bei astrazeneca.com
Titel
Zitiert von
Zitiert von
Jahr
Structures of closed and open conformations of dimeric human ATM
D Baretić, HK Pollard, DI Fisher, CM Johnson, B Santhanam, CM Truman, ...
Science advances 3 (5), e1700933, 2017
1092017
Discovery of AZD9833, a potent and orally bioavailable selective estrogen receptor degrader and antagonist
JS Scott, TA Moss, A Balazs, B Barlaam, J Breed, RJ Carbajo, ...
Journal of Medicinal Chemistry 63 (23), 14530-14559, 2020
662020
Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the …
DI Fisher, ST Safrany, P Strike, AG McLennan, JL Cartwright
Journal of Biological Chemistry 277 (49), 47313-47317, 2002
662002
Systematic evaluation of CRISPRa and CRISPRi modalities enables development of a multiplexed, orthogonal gene activation and repression system
A Martella, M Firth, BJM Taylor, A Göppert, EM Cuomo, RG Roth, ...
ACS Synthetic Biology 8 (9), 1998-2006, 2019
422019
Characterization of a Nudix hydrolase from Deinococcus radiodurans with a marked specificity for (deoxy)ribonucleoside 5'-diphosphates
DI Fisher, JL Cartwright, H Harashima, H Kamiya, AG McLennan
BMC biochemistry 5, 1-8, 2004
312004
Correlation of intracellular diadenosine triphosphate (Ap3A) with apoptosis in Fhit-positive HEK293 cells
DI Fisher, AG McLennan
Cancer letters 259 (2), 186-191, 2008
302008
Optimisation of a simple method to transiently transfect a CHO cell line in high-throughput and at large scale
WM Abbott, B Middleton, F Kartberg, J Claesson, R Roth, D Fisher
Protein Expression and Purification 116, 113-119, 2015
282015
Structural insights into the critical DNA damage sensors DNA-PKcs, ATM and ATR
D Baretic, TM de Oliveira, M Niess, P Wan, H Pollard, CM Johnson, ...
Progress in biophysics and molecular biology 147, 4-16, 2019
262019
Use of a protein engineering strategy to overcome limitations in the production of “Difficult to Express” recombinant proteins
H Hussain, DI Fisher, WM Abbott, RG Roth, AJ Dickson
Biotechnology and bioengineering 114 (10), 2348-2359, 2017
212017
Characterization of the Mn2+-stimulated (di)adenosine polyphosphate hydrolase encoded by the Deinococcus radiodurans DR2356 nudix gene
DI Fisher, JL Cartwright, AG McLennan
Archives of microbiology 186, 415-424, 2006
122006
Discovery of AZD9833, an oral small molecule selective degrader of the estrogen receptor (SERD)
JS Scott, T Moss, S Stokes, WM Nissink, CJ Morrow, M Lawson, ...
Cancer Research 80 (16_Supplement), 5674-5674, 2020
112020
Phosphorylation of the multifunctional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2
JU Lauenstein, A Udgata, A Bartram, D De Sutter, DI Fisher, S Halabi, ...
Journal of Biological Chemistry 294 (52), 19852-19861, 2019
112019
A protein chimera strategy supports production of a model “difficult‐to‐express” recombinant target
H Hussain, DI Fisher, RG Roth, W Mark Abbott, MA Carballo‐Amador, ...
FEBS letters 592 (14), 2499-2511, 2018
112018
Chromosome-level genome assembly and population genomic resource to accelerate orphan crop lablab breeding
I Njaci, B Waweru, N Kamal, MS Muktar, D Fisher, H Gundlach, C Muli, ...
Nature Communications 14 (1), 1915, 2023
102023
Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1
J Luptak, M Bista, D Fisher, L Flavell, N Gao, K Wickson, SL Kazmirski, ...
Acta Crystallographica Section D: Structural Biology 75 (11), 1003-1014, 2019
102019
Regulation of gene expression and the elucidative role of CRISPR-based epigenetic modifiers and CRISPR-induced chromosome conformational changes
A Martella, DI Fisher
The CRISPR Journal 4 (1), 43-57, 2021
92021
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-Antagonists
JS Scott, D Stead, B Barlaam, J Breed, RJ Carbajo, E Chiarparin, ...
Journal of Medicinal Chemistry 66 (4), 2918-2945, 2023
72023
Development of a medium-throughput targeted LCMS assay to detect endogenous cellular levels of malonyl-CoA to screen fatty acid synthase inhibitors
PJ Hopcroft, DI Fisher
Journal of Biomolecular Screening 21 (2), 111-116, 2016
72016
Negative regulation of TLR signaling by BCAP requires dimerization of Its DBB domain
JU Lauenstein, MJ Scherm, A Udgata, MC Moncrieffe, DI Fisher, NJ Gay
The Journal of Immunology 204 (8), 2269-2276, 2020
62020
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and …
M Lawson, N Cureton, S Ros, A Cheraghchi-Bashi, J Urosevic, S D'Arcy, ...
Cancer Research 83 (23), 3989-4004, 2023
52023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20